FDA Inspection 1279060 — Laboratorios Liconsa SAU

Laboratorios Liconsa SAU — FEI 3005508367

The FDA completed an inspection of Laboratorios Liconsa SAU on April 19, 2023 in Azuqueca De Henares. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Azuqueca De Henares (Spain)

Additional Details

Mutual Recognition Agreement (MRA)